Improving Psychosocial Functioning in Older Veterans With PTSD
1 other identifier
interventional
34
1 country
1
Brief Summary
The purpose of this project is to develop an intervention to improve psychosocial functioning and quality of life for older Veterans with partial or full PTSD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2016
CompletedFirst Posted
Study publicly available on registry
June 16, 2016
CompletedStudy Start
First participant enrolled
November 14, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 9, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 23, 2022
CompletedResults Posted
Study results publicly available
August 1, 2024
CompletedAugust 1, 2024
April 1, 2024
4.8 years
May 19, 2016
October 19, 2023
April 30, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Inventory of Psychosocial Functioning (IPF) - Romantic, Family, Friends/Socializing Subscales
The IPF is an 80-item self-report measure designed to assess functional impairment experienced by Veterans. Respondents rate how often they have acted a certain way over the past 30 days. Items are rated on a 7-point scale ranging from 0 ("never") to 6 ("always"). The IPF yields a total score (0-66) and scores for seven subscales: romantic relationships, family, work, friendships and socializing, parenting, education, and self-care functioning (lower indicates better functioning/less impairment). Respondents have the option to skip sections that do not apply to them. The IPF has excellent internal consistency reliability (overall alpha = .93) and the scale correlates with other self-report measures of quality of life and functional impairment, such as the QOLI (r = .59). Reporting on romantic relationships (range = 0-66), family (range = 0-42), and friends/socializing (range = 0-48) functioning subscales here. Higher scores indicate more impairment.
Reporting on baseline and post-group assessment (assessed at the final group session, approximately 2.5 - 3 months after baseline)
Quality of Life Inventory (QOLI)
The QOLI is a 32 item self-report measure that assesses life satisfaction across 16 life domains (e.g., health, work, recreation). For each domain, the respondent rates how important the domain is on a 0-2 scale and how satisfied he or she is in this area of life on a 7-point scale. Satisfaction scores on the measure are weighted based on the respondent's rating of the importance of the life domain in order to achieve a total score with higher scores indicating higher quality of life. The measure was validated across a number of samples, including psychiatric inpatient and outpatient VA samples. Test-retest reliability was excellent over a one-month interval (r = .91) as was the internal consistency of the measure (alphas ranged from .86-.89). The measure also demonstrated convergent and discriminant validity with other measures of life satisfaction. T scores were used with range 0 - 100, Mean (of reference population) =50, Standard deviation = 10
Reporting on baseline and post-group scores (assessed at the final group session, approximately 2.5 - 3 months after baseline)
Veterans Rand 12-item (VR-12) Health Survey
The VR-12 is a 12-item scale that assesses the effects of physical and mental health on well-being, and is often used to assess quality of life. Item scores are used to compute two broad component scores: the physical component score (PCS) and the mental component score (MCS). The component scores are standardized T-Scores and the population standard for this measure was recently updated. Higher scores indicate better functioning. T scores were used with range 0 - 100, Mean (of reference population) = 50, Standard deviation = 10
Reporting on baseline and post-group scores (assessed at the final group session, approximately 2.5 - 3 months after baseline)
Study Arms (2)
Developed psychosocial intervention
ACTIVE COMPARATORThe active intervention in this study that will be compared to support group control
Support group control
PLACEBO COMPARATORThis is the comparison group
Interventions
This intervention is to be developed during the study. It will likely include modules that provide anger management strategies, communication skills, and education about interpersonal relationships and social support. In addition, psychoeducation about behavioral activation and stress management will likely be included
The support groups will be process-oriented in nature with core elements manualized to facilitate consistency of the intervention. In particular, group leaders will facilitate a check-in with the group, and the agenda will be open to topics brought in by group members
Eligibility Criteria
You may qualify if:
- Focus groups:
- Veterans need to be at least 60 years old to be eligible to participate in the focus groups.
- Potential participants will be assessed with the Primary Care Posttraumatic Stress Disorder Screener (PC-PTSD-5) prior to being invited to participate.
- Pilot:
- Veterans need to be at least 60 years old to be eligible to participate in the study.
- Potential participants will be assessed for PTSD symptoms.
- Comparison:
- Veterans need to be at least 60 years old to be eligible to participate in the study.
- For both intervention and support groups, participants (who will be assessed for PTSD), must endorse a military-related criterion A event and several PTSD symptoms.
You may not qualify if:
- Focus groups:
- Veterans who are diagnosed with a psychotic disorder or have psychotic symptoms, have been hospitalized for suicidal ideation or psychosis within the past year, or have a diagnosis of dementia or other severe cognitive disorder.
- Potential participants will also be excluded if they do not agree to be audio recorded.
- Pilot:
- Veterans who are in current treatment for PTSD, are diagnosed with a psychotic disorder or have psychotic symptoms, have been hospitalized for suicidal ideation or psychosis within the past year, or have a diagnosis of dementia or other severe cognitive disorder.
- Veterans will be asked not to join therapy groups or other interventions for the duration of their participation in the study.
- Potential participants will also be excluded if they do not agree to be audio recorded.
- Comparison:
- Veterans who are in current treatment for PTSD, are diagnosed with a psychotic disorder or have psychotic symptoms, have been hospitalized for suicidal ideation or psychosis within the past year, or have a diagnosis of dementia or other severe cognitive disorder.
- Veterans will be asked not to join therapy groups or other interventions for the duration of their participation in the study.
- Potential participants will also be excluded if they do not agree to be audio recorded.
- In addition, Veterans who participated in the pilot phase of the study will be excluded from participating in the comparison condition phase.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Boston, Massachusetts, 02130, United States
Related Publications (2)
Pless Kaiser A, Ream M, Spiro A, Sloan DM, Cook JM, Vogt D, Moye JA. Feasibility, acceptability, and outcomes: A pilot trial of the enhancing social function in older veterans with PTSD (ESVP) group intervention. Psychol Serv. 2025 Jun 26:10.1037/ser0000962. doi: 10.1037/ser0000962. Online ahead of print.
PMID: 40569724DERIVEDPless Kaiser A, Daks JS, Korsun L, Heintz H, Moye J, Sloan DM, Cook JM, Vogt D, Spiro A 3rd. Enhancing social functioning in older veterans with PTSD: Rationale and design of an intervention and initial RCT. Contemp Clin Trials. 2024 Apr;139:107485. doi: 10.1016/j.cct.2024.107485. Epub 2024 Mar 2.
PMID: 38432471DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Anica Pless Kaiser, PhD
- Organization
- VA Boston Healthcare System
Study Officials
- PRINCIPAL INVESTIGATOR
Anica Pless Kaiser, PhD
VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2016
First Posted
June 16, 2016
Study Start
November 14, 2017
Primary Completion
September 9, 2022
Study Completion
September 23, 2022
Last Updated
August 1, 2024
Results First Posted
August 1, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share
Any data to be shared will be coded data within a limited dataset, with appropriate Data Use Agreement (DUA) in place.